Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × liposomal doxorubicin × 90 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 11 Fallopian Tube Neoplasms 7 Breast Neoplasms 5 Triple Negative Breast Neoplasms 3 Sarcoma, Kaposi 2 Sarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasms 2 Neoplasm Metastasis 2 Multi-centric Castleman's Disease 2 Carcinoma, Ovarian Epithelial 2 Acquired Immunodeficiency Syndrome 2 Vaccinia 1 Sarcoma, Ewing 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphoma, Follicular 1 Lymphoma 1 Lymphadenopathy 1 Low Grade Serous Ovarian Cancer 1 Leiomyosarcoma 1 Hodgkin Disease 1 HIV Infections 1 AIDS-related Kaposi sarcoma 1

Interventions

Cyclophosphamide 9 Vincristine 7 venetoclax 5 prednylidene 5 deltacortene 5 Prednisone 5 Doxorubicin 5 merphos 4 dexamethasone acetate 4 dexamethasone 21-phosphate 4 auricularum 4 Methotrexate 4 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 Etoposide 4 Dexamethasone 4 Cytarabine 4 Calcium Dobesilate 4 pegaspargase 3 calaspargase pegol 3 Stem Cell Transplantation 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 nelarabine 2 mogamulizumab 2 fludarabine phosphate 2 fludarabine 2 exifone 2 azathiopurine 2 Whole-Body Irradiation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡